1 – 10 of 3611
- show: 10
- |
- sort: year (new to old)
- |
- Export
- 2026
- Does It Make Sense to Perform Prostate Magnetic Resonance Imaging in Men with Normal PSA (<4 ng/mL)? (2026) Cancers. 18(3).
- Pelvic lymph node dissection during radical prostatectomy for prostate cancer: harms versus benefits. (2026) Urologia Internationalis. p.1-21
- Perceptions and Barriers to Transition in Urological Care among Adolescents - STREAMWAY Interim Analysis (2026)
- Heelkundige uitkomst na lymfeklierdissectie bij lokaal gevorderd renaal cel carcinoom : een retrospectieve analyse (2026) TIJDSCHRIFT VOOR GENEESKUNDE.
- Optimizing oncological and functional outcomes in localized and metastatic prostate cancer patients (2026)
- Authors' reply to : comment on 'Feasibility of randomisation to radical prostatectomy or standard care in patients with metastatic prostate cancer' (2026) BJU INTERNATIONAL.
- Nocturia : when the heart wakes you up at night (2026) WORLD JOURNAL OF UROLOGY. 44(1).
- Mechanical characterization of the equine linea alba and finite element modeling of suture patterns effects on its closure (2026) JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS. 173.
- Health-related quality of life outcomes of salvage metastasis-directed treatment versus elective nodal treatment for oligorecurrent nodal prostate cancer : a secondary analysis of the phase 2, open-label PEACE V–STORM randomized trial (2026) EUROPEAN UROLOGY ONCOLOGY.
- Metastasis-directed therapy and standard of care versus standard of care for oligometastatic prostate cancer (WOLVERINE) : a systematic review and individual patient data meta-analysis from the X-MET collaboration (2026) LANCET ONCOLOGY. 27(2). p.181-190